Skip to main content
. 2018 Feb;100:68–74. doi: 10.1016/j.peptides.2017.11.008

Fig. 1.

Fig. 1

Effects of Monoacylglycerol (MOG) and sodium taurocholate (STC) capsules on GLP-1 levels in healthy humans.

A,B. The effect of 10 capsules of either placebo (A) or MOG (5.6 g, B), delivered at time = 0, on plasma concentrations of GLP-1. Data from individual participants are shown: the same participant is shown by the same colour in A and B (n = 5).

C,D. The effect of 10 capsules of either placebo (C) or STC (3.75 g, D), delivered at time = 0, on plasma concentrations of GLP-1. Data from individual participants are shown: the same participant is shown by the same colour in C and D (n = 7).